Helixtalk - Rosalind Franklin University's College Of Pharmacy Podcast
076 - The New Move: Treating Tardive Dyskinesia
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:36:06
- Mais informações
Informações:
Sinopse
In this episode, we discuss two new agents (valbenazine and deutetrabenazine) -- the first of their kind to receive FDA approval to manage tardive dyskinesia most commonly associated with antipsychotic use.
